<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00315913</url>
  </required_header>
  <id_info>
    <org_study_id>HS #2004-3997</org_study_id>
    <nct_id>NCT00315913</nct_id>
  </id_info>
  <brief_title>Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor</brief_title>
  <official_title>Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether propranolol is better than oxytocin for the
      treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by
      women receiving prolonged oxytocin versus propranolol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial was designed to test if propranolo can reduce the c section rate for dysfuctional
      labor. Due to stringent inclution and exclusion criteria and low enrollment the study was
      closed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low study enrollment
  </why_stopped>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal delivery rates</measure>
    <time_frame>at time of delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cesarean section rates</measure>
    <time_frame>at time of cesarean rates</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes</measure>
    <time_frame>at time of delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal safety</measure>
    <time_frame>assessed during labor</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Dysfunctional Labor</condition>
  <arm_group>
    <arm_group_label>IV Propranolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV dose propranolol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV Placebo of saline solution equal to propranolol in volume</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>IV Propranolol 1mg/min for a total of 2 minutes. Total dose 2mg</description>
    <arm_group_label>IV Propranolol</arm_group_label>
    <other_name>Inderal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV Placebo</intervention_name>
    <description>IV Saline Solution</description>
    <arm_group_label>IV Placebo</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be term pregnancy (&gt; 37 weeks)

          -  Vertex presentation

          -  Active labor (4-5 centimeters dilated)

        Exclusion Criteria:

          -  Heart disease

          -  Diabetes

          -  Currently taking propranolol

          -  Contraindications to labor or vaginal delivery

          -  Multiple gestations

          -  Preterm

          -  Chorioamnionitis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leah R Battista, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2006</study_first_submitted>
  <study_first_submitted_qc>April 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2006</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Deborah A. Wing</investigator_full_name>
    <investigator_title>Professor and MFM Division Director</investigator_title>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Dysfunctional Labor</keyword>
  <keyword>Labor Arrest</keyword>
  <keyword>Primary Cesarean Section Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystocia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
    <mesh_term>Propranolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

